Summit Therapeutics Inc. (NASDAQ:SMMT) has 202 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,998,128 | 27.13% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 2,668,089 | 7.91% | $0.00 |
| Polymer Capital Management (HK) LTD | 31 Dec, 2025 | 0 | 603,879 | 73.89% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -387,505 | -53.38% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 4,442,920 | 49.82% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | -220,388 | -13.74% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 197,532 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -202,508 | -1.78% | $0.00 |
| APEIRON CAPITAL Ltd | 31 Dec, 2025 | 0 | -1,700 | -0.13% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 274,425 | 4.31% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | -212,359 | -18.64% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 14,745 | 0.47% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -408,064 | -31.91% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 2,272,996 | 1,121.29% | $0.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 0 | 605,584 | 551.40% | $0.00 |
| NORGES BANK | 31 Dec, 2025 | 0 | 1,373,943 | 0.00% | $0.00 |
| READYSTATE ASSET MANAGEMENT LP | 31 Dec, 2025 | 0 | 306,184 | 0.00% | $0.00 |
| TD ASSET MANAGEMENT INC | 31 Dec, 2025 | 0 | 667,742 | 124.22% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -1,000,249 | -51.91% | $0.00 |